Created in 2004 (United States), Taligen Therapeutics own 584 sister brands and 17477 competing brands. Taligen Therapeutics is owned by ASTRAZENECA, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB0009895292. Taligen Therapeutics belongs to the Drug Manufacturers business sector.

Taligen Therapeutics is a brand of ASTRAZENECA (AZN/L) Share price

Date created : 2004 Business sector Drug Manufacturers

Share price and profitability of the share ASTRAZENECA (Taligen Therapeutics)

Buy ASTRAZENECA share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested GBX 12,008.00

Portfolio valuation
ASTRAZENECA (Taligen Therapeutics) over 5 years* GBX 24,948.16

Stock market history ASTRAZENECA (Taligen Therapeutics)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
ASTRAZENECA

Icosavax
Icosavax
Ardea Biosciences
Ardea Biosciences
ZS Pharma
ZS Pharma
Acerta Pharma
Acerta Pharma
Synageva BioPharma
Synageva BioPharma
Enobia Pharma
Enobia Pharma
See more brands of ASTRAZENECA

Rival brands
Taligen Therapeutics

POINT BIOPHARMA
POINT BIOPHARMA
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
ZARBEE'S
ZARBEE'S
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS